Erratum to Retraction Note to: Decreased Warburg effect induced by ATP citrate lyase suppression inhibits tumor growth in pancreatic cancer (Med Oncol, (2015), 10.1007/s12032-015-0540-z);Decreased Warburg effect induced by ATP citrate lyase suppression inhibits tumor growth in pancreatic cancer

Medical Oncology

Volumn 32, Issue 3, 2015, Pages 1-7

  Zong, Haifeng ^a   Zhang, Yang ^a   You, Yong ^b   Cai, Tiantian ^a   Wang, Yehuang ^a  

^a Nanjing Municipal Hospital of TCM   (China)

^b Zhangjiagang Wandong Anorectal Hospital   (China)

Author keywords

ACLY; Growth; Pancreatic cancer; Warburg effect

Indexed keywords

ADENOSINE TRIPHOSPHATE CITRATE SYNTHASE; CASPASE 3; CASPASE 7; DEOXYGLUCOSE; GLUCOSE; LACTIC ACID;

ADENOCARCINOMA CELL LINE; APOPTOSIS; ARTICLE; CANCER INHIBITION; CANCER PROGNOSIS; CELL GROWTH; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVITY; GLUCOSE INTAKE; GLUCOSE TRANSPORT; HUMAN; HUMAN CELL; HUMAN TISSUE; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL;

EID: 84923273462     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-015-0685-9     Document Type: Erratum

References (24)

1. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014;64(1):9–29. doi:10.3322/caac.21208.
2. The Lancet Oncology. Pancreatic cancer in the spotlight. Lancet Oncol. 2014;15(3):241. doi:10.1016/S1470-2045(14)70097-X.
3. Finley LW, Zhang J, Ye J, Ward PS, Thompson CB. SnapShot: cancer metabolism pathways. Cell Metab. 2013;17(3):466. doi:10.1016/j.cmet.2013.02.016.
4. Watson JA, Fang M, Lowenstein JM. Tricarballylate and hydroxycitrate: substrate and inhibitor of ATP: citrate oxaloacetate lyase. Arch Biochem Biophys. 1969;135(1):209–17.
5. Yancy HF, Mason JA, Peters S, Thompson CE 3rd, Littleton GK, Jett M, et al. Metastatic progression and gene expression between breast cancer cell lines from African American and Caucasian women. J Carcinog. 2007;6:8. doi:10.1186/1477-3163-6-8.
6. Migita T, Narita T, Nomura K, Miyagi E, Inazuka F, Matsuura M, et al. ATP citrate lyase: activation and therapeutic implications in non-small cell lung cancer. Cancer Res. 2008;68(20):8547–54. doi:10.1158/0008-5472.CAN-08-1235.
7. Varis A, Wolf M, Monni O, Vakkari ML, Kokkola A, Moskaluk C, et al. Targets of gene amplification and overexpression at 17q in gastric cancer. Cancer Res. 2002;62(9):2625–9.
8. Turyn J, Schlichtholz B, Dettlaff-Pokora A, Presler M, Goyke E, Matuszewski M, et al. Increased activity of glycerol 3-phosphate dehydrogenase and other lipogenic enzymes in human bladder cancer. Horm Metab Res. 2003;35(10):565–9. doi:10.1055/s-2003-43500.
9. Zhou Y, Bollu LR, Tozzi F, Ye X, Bhattacharya R, Gao G, et al. ATP citrate lyase mediates resistance of colorectal cancer cells to SN38. Mol Cancer Ther. 2013;12(12):2782–91. doi:10.1158/1535-7163.MCT-13-0098.
10. Gao Y, Islam MS, Tian J, Lui VW, Xiao D. Inactivation of ATP citrate lyase by Cucurbitacin B: a bioactive compound from cucumber, inhibits prostate cancer growth. Cancer Lett. 2014;349(1):15–25. doi:10.1016/j.canlet.2014.03.015.
11. Hatzivassiliou G, Zhao F, Bauer DE, Andreadis C, Shaw AN, Dhanak D, et al. ATP citrate lyase inhibition can suppress tumor cell growth. Cancer Cell. 2005;8(4):311–21. doi:10.1016/j.ccr.2005.09.008.
12. Mashima T, Seimiya H, Tsuruo T. De novo fatty-acid synthesis and related pathways as molecular targets for cancer therapy. Br J Cancer. 2009;100(9):1369–72. doi:10.1038/sj.bjc.6605007.
13. Bauer DE, Hatzivassiliou G, Zhao F, Andreadis C, Thompson CB. ATP citrate lyase is an important component of cell growth and transformation. Oncogene. 2005;24(41):6314–22. doi:10.1038/sj.onc.1208773.
14. Warburg O. On respiratory impairment in cancer cells. Science. 1956;124(3215):269–70.
15. Ying H, Kimmelman AC, Lyssiotis CA, Hua S, Chu GC, Fletcher-Sananikone E, et al. Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism. Cell. 2012;149(3):656–70. doi:10.1016/j.cell.2012.01.058.
16. MacDonald MJ, Smith AD 3rd, Hasan NM, Sabat G, Fahien LA. Feasibility of pathways for transfer of acyl groups from mitochondria to the cytosol to form short chain acyl-CoAs in the pancreatic beta cell. J Biol Chem. 2007;282(42):30596–606. doi:10.1074/jbc.M702732200.
17. MacDonald MJ, Longacre MJ, Langberg EC, Tibell A, Kendrick MA, Fukao T, et al. Decreased levels of metabolic enzymes in pancreatic islets of patients with type 2 diabetes. Diabetologia. 2009;52(6):1087–91. doi:10.1007/s00125-009-1319-6.
18. Zaidi N, Swinnen JV, Smans K. ATP-citrate lyase: a key player in cancer metabolism. Cancer Res. 2012;72(15):3709–14. doi:10.1158/0008-5472.CAN-11-4112.
19. Beigneux AP, Kosinski C, Gavino B, Horton JD, Skarnes WC, Young SG. ATP-citrate lyase deficiency in the mouse. J Biol Chem. 2004;279(10):9557–64. doi:10.1074/jbc.M310512200.
20. Migita T, Okabe S, Ikeda K, Igarashi S, Sugawara S, Tomida A, et al. Inhibition of ATP citrate lyase induces an anticancer effect via reactive oxygen species: AMPK as a predictive biomarker for therapeutic impact. Am J Pathol. 2013;182(5):1800–10. doi:10.1016/j.ajpath.2013.01.048.
21. Lee JH, Jang H, Lee SM, Lee JE, Choi J, Kim TW, et al. ATP-citrate lyase regulates cellular senescence via an AMPK- and p53-dependent pathway. FEBS J. 2015;282(2):361–71. doi:10.1111/febs.13139.
22. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646–74. doi:10.1016/j.cell.2011.02.013.
23. Potapova IA, El-Maghrabi MR, Doronin SV, Benjamin WB. Phosphorylation of recombinant human ATP:citrate lyase by cAMP-dependent protein kinase abolishes homotropic allosteric regulation of the enzyme by citrate and increases the enzyme activity. Allosteric activation of ATP:citrate lyase by phosphorylated sugars. Biochemistry. 2000;39(5):1169–79.
24. Beckner ME, Fellows-Mayle W, Zhang Z, Agostino NR, Kant JA, Day BW, et al. Identification of ATP citrate lyase as a positive regulator of glycolytic function in glioblastomas. Int J Cancer. 2010;126(10):2282–95. doi:10.1002/ijc.24918.